Transaction · 0001231919-26-001469

Qiming Corporate GP VI, Ltd.

Qiming Corporate GP VI, Ltd., 10%, reported an open-market or private sale at Alamar Biosciences, Inc. involving 21.000000 shares for an estimated $567.42. Reported holdings after the transaction were 1579324.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code S10%
ALMRAlamar Biosciences, Inc.
Trade date
Oct 16, 2026
Filing date
Oct 19, 2026
View on SEC Insider profile
Estimated value-$567Shares × reported price
Shares traded21$27.02 per share
Holdings after1.57MIndirect · See footnote
% of reported position traded<0.01%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,579,345 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ALMR price since this filing

Daily closing prices, with the filing date and available return windows
ALMR · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago -7.8%1d ago +0.0%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001231919-26-001469
Common Stock
Transaction date
Oct 16, 2026
Filed Oct 19, 2026, 08:30 PM · 3d delay
Shares
21 sh
$27.02 per share
Estimated value
-$567
Computed from shares × price
Holdings after
1,579,324 sh
Indirect · See footnote

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Repeat Seller
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
    Read the scoring methodology

    Signed filing-only points, not a probability or expected return. Version v1.

    Reported relationships & other filings

    Form 4 relationship flags and nearby filing context

    Reported roles

    No officer title

    Officer NoDirector No10% YesOther No
    Footnotes & amended
    1. F1

      The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.26 to $28.23,

    2. inclusive. The reporting person undertakes to provide to Alamar Biosciences, Inc., any security holder of Alamar Biosciences, Inc., or the staff of the

    3. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set

    4. forth in this footnote (1) to this Form 4.

    5. F2

      These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Mana…

    6. F3

      These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Ventur…

    7. F4

      These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of Q…

    8. F5

      These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispo…

    Original filing · 0001231919-26-001469
    Related transactions

    0 other transactions

    Same SEC filing
    Recent company activity

    0 recent txs

    ALMR